Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder
Reduktionen der WHO-Risikotrinkniveaus korrelieren mit Alkoholverlangen bei Personen mit Alkoholgebrauchsstörung
Alcohol, Clinical and Experimental Research · 2024-02 · 48 (2) · 420-429
DOI: 10.1111/acer.15257 ↗Auf einen Blick
Sekundäranalysen von 3 klinischen Studien zeigen: Wer mindestens 1 oder 2 WHO-Risikotrinkniveaus reduzierte, berichtete am Behandlungsende weniger Craving.
Fragestellung
Sind Reduktionen des Alkoholkonsums während der Behandlung mit geringerem Alkoholverlangen am Behandlungsende verbunden?
Methode
Sekundäranalysen von Daten aus 3 AUD-Studien; Trinkreduktionen von Baseline bis Behandlungsende als Änderung der WHO-Risikotrinkniveaus; Regression und Moderationsanalysen.
Ergebnisse
Daten aus 3 Studien mit N=1327, 346 und 200. Reduktionen um mindestens 1 oder 2 WHO-Risikotrinkniveaus waren mit niedrigerem Craving verbunden (alle p<0,05).
Schlussfolgerung der Autor:innen
Personen mit Reduktionen der WHO-Risikotrinkniveaus berichteten signifikant weniger Craving als Personen ohne relevante Trinkreduktion. Die Autor:innen sehen WHO-Risikotrinkniveaus als nützliche Endpunkte in AUD-Studien.
Kernaussagen
- Reduktionen um ≥1 oder ≥2 WHO-Risikotrinkniveaus waren mit weniger Craving verbunden
- Der Zusammenhang blieb auch ohne Personen mit Abstinenz am Studienende ähnlich
- AUD-Schweregrad moderierte die Zusammenhänge meist nicht
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Alcohol, Clinical and Experimental Research, online erschienen am 11.01.2024. Verfasst von Felicia R Tuchman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of New Mexico, Albuquerque, New Mexico, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism, VISN 4 Mental Illness Research, Education, and Clinical Center.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background
Abstinence has historically been considered the preferred goal of alcohol use disorder (AUD) treatment. However, most individuals with AUD do not want to abstain and many are able to reduce their drinking successfully. Craving is often a target of pharmacological and behavioral interventions for AUD, and reductions in craving may signal recovery. Whether reductions in drinking during AUD treatment are associated with reductions in craving has not been well examined.
Methods
We conducted secondary analyses of data from three AUD clinical trials ( N 's= 1327, 346, and 200). Drinking reductions from baseline to the end of treatment were measured as changes in World Health Organization (WHO) risk drinking levels; alcohol craving was measured using validated self‐report measures. Regression analyses tested whether drinking reductions were associated with end‐of‐treatment craving reductions; moderation analyses tested whether associations between drinking reduction and end‐of‐treatment craving differed across AUD severity.
Results
Reductions of at least 1 or at least 2 WHO risk drinking levels were associated with lower craving (all p 's < 0.05). Results were substantively similar after removing abstainers at the end‐of‐treatment. Associations between drinking reductions and craving were generally not moderated by AUD severity.
Conclusions
Individuals with WHO risk drinking level reductions reported significantly lower craving, as compared to those who did not achieve meaningful reductions in drinking. The results demonstrate the utility of WHO risk drinking levels as AUD clinical trial endpoints and provide evidence that drinking reductions mitigate craving.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, University of New Mexico, Albuquerque, New Mexico, USA.
- Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.
- Center on Alcohol, Substance use, and Addictions (CASAA), University of New Mexico, Albuquerque, New Mexico, USA.
- Behavioral Health Financing, Economics and Evaluation Department, Research Triangle Institute (RTI) International, Durham, North Carolina, USA.
- Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
- AP-HP, Université Paris Saclay, French Institute of Health and Medical Research (INSERM), Paris, Île-de-France, France.
ORCID-Profile: Felicia R Tuchman, Kevin A Hallgren, Dylan K Richards, Raymond F Anton, Henri-Jean Aubin, Henry R Kranzler, Karl Mann, Stephanie S O'Malley, Katie Witkiewitz
Förderung
- NIAAA NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
- VISN 4 Mental Illness Research, Education, and Clinical Center
Zitieren
APA
Tuchman, F. R., Hallgren, K. A., Richards, D. K., Aldridge, A., Anton, R. F., Aubin, H. J., Kranzler, H. R., Mann, K., O'Malley, S. S., & Witkiewitz, K. (2024). Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder. Alcohol, Clinical and Experimental Research, 48(2), 420-429. https://doi.org/10.1111/acer.15257
Vancouver
Tuchman FR, Hallgren KA, Richards DK, Aldridge A, Anton RF, Aubin HJ, et al. Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder. Alcohol, Clinical and Experimental Research. 2024;48(2):420-429. doi:10.1111/acer.15257
BibTeX
@article{Tuchman2024,
author = {Tuchman, Felicia R and Hallgren, Kevin A and Richards, Dylan K and Aldridge, Arnie and Anton, Raymond F and Aubin, Henri-Jean and Kranzler, Henry R and Mann, Karl and O'Malley, Stephanie S and Witkiewitz, Katie},
title = {Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder},
journal = {Alcohol, Clinical and Experimental Research},
year = {2024},
volume = {48},
number = {2},
pages = {420--429},
doi = {10.1111/acer.15257}
}
EUVIMED